1. Home
  2. ATLX vs MXCT Comparison

ATLX vs MXCT Comparison

Compare ATLX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$3.20

Market Cap

124.5M

Sector

Industrials

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.42

Market Cap

136.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
MXCT
Founded
2011
1999
Country
Brazil
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
136.0M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
ATLX
MXCT
Price
$3.20
$1.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$12.00
$5.50
AVG Volume (30 Days)
415.1K
1.7M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
47.08
N/A
EPS
N/A
N/A
Revenue
$92,491.00
$33,026,000.00
Revenue This Year
$64,564.67
N/A
Revenue Next Year
$785.59
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.07
$0.64
52 Week High
$8.25
$2.37

Technical Indicators

Market Signals
Indicator
ATLX
MXCT
Relative Strength Index (RSI) 33.56 74.15
Support Level N/A $0.77
Resistance Level $3.92 $1.71
Average True Range (ATR) 0.21 0.08
MACD -0.02 0.01
Stochastic Oscillator 15.88 78.33

Price Performance

Historical Comparison
ATLX
MXCT

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: